8398
S. Gauthier et al. / Tetrahedron 69 (2013) 8392e8399
4.11. General procedure B for Sonogashira cross-coupling
reaction
7.02 (s, 2H), 7.47e7.42(m, 17H), 7.61(d, 2H, J¼8 Hz), 7.77e7.75 (m,
8H), 9.16 (s, 1H); 13C NMR and JMOD (75 MHz, CDCl3)
153.6 (C),
d
151.5 (C), 151.0 (C), 140.8 (C), 133.2 (C), 133.0 (C), 132.7 (CH), 133.2
(C), 129.6 (CH), 129.3 (CH), 128.71 (CH), 128.68 (CH), 127.6 (CH),
125.4 (CH), 125.0 (CH), 124.6 (CH), 117.2 (C), 113.2 (CH), 108.6 (CH),
101.9 (CH), 95.9 (C), 87.2 (C). HRMS (ESI/ASAP) m/z calculated for
Compound 4 (1 equiv per iodine atom), NEt3 (0.5 mL), CuI
(6 mol %), and Pd(PPh3)2Cl2 (6 mol %) were added to iododiazine
(1 mmol) in THF (5 mL). The suspension was stirred at room tem-
perature overnight under nitrogen atmosphere. The suspension
was then diluted with a mixture of water and dichloromethane
(1:1, 20 mL) and the organic layer separated. The aqueous layer was
extracted with dichloromethane (2ꢃ20 mL). The combined organic
extracts were dried over MgSO4, filtered, and evaporated.
C
56H37N2O2 [MꢀH]þ: 769.2855, found 769.2849.
4.16. 2,4-Bis-[4-(2,6-diphenyl-pyran-4-ylidenemethyl)-phe-
nylethynyl]-pyrimidine (15)
Red solid; obtained according to the general procedure B and
purified by column chromatography (SiO2, Petroleum Ether/CH2Cl2,
1:1 then CH2Cl2, then CH2Cl2/MeOH 9:1); yield 40% (307 mg); mp:
4.12. 2-[4-(2,6-Diphenyl-pyran-4-ylidenemethyl)-phenyl-
ethynyl]-pyrazine (11)
125e126 ꢁC; 1H NMR (300 MHz, CDCl3)
d 5.92 (s, 2H), 6.44 (s, 2H),
Orange solid; obtained according to the general procedure B and
purified by column chromatography (SiO2, Petroleum Ether/CH2Cl2,
1:1 then CH2Cl2, then CH2Cl2/MeOH, 95:5); yield 48% (203 mg);
7.02 (s, 2H), 7.34 (d, 1H, J¼5.1 Hz), 7.47e7.37 (m, 16H), 7.60 (d, 2H,
J¼8 Hz), 7.66 (d, 2H, J¼8 Hz), 7.79e7.76 (m, 8H), 8.72 (d, 1H,
J¼5.1 Hz); 13C NMR and JMOD (75 MHz, CDCl3)
d 157.4 (CH), 153.7
mp: 156e157 ꢁC; 1H NMR (400 MHz, CDCl3)
d 5.91 (s, 1H), 6.43 (s,
(C), 153.6 (C), 151.68 (C), 151.65 (C), 151.5 (C), 140.9 (C), 140.5 (C),
133.44 (C), 133.40 (C), 133.3 (CH), 133.2 (CH), 133.1 (CH), 133.0 (CH),
131.3 (C), 131.0 (C), 129.7 (CH), 129.6 (CH), 129.4 (CH), 129.3 (CH),
128.80 (CH), 128.77 (CH), 127.8 (CH), 127.7 (CH), 125.1 (CH), 124.7
(CH), 121.4 (CH), 117.8 (C), 117.4 (C), 113.5 (CH), 113.3 (CH), 108.81
(CH), 108.78 (CH) 102.11 (CH), 102.07 (CH), 95.9 (C), 89.4 (C), 88.6
(C), 87.2 (C). HRMS (ESI/ASAP) m/z calculated for C56H37N2O2
[MþH]þ: 769.2855, found 769.2852.
1H), 7.01 (s, 1H), 7.46e7.40 (m, 8H), 7.59 (d, 2H, J¼8 Hz), 7.77e7.76
(m, 4H), 8.48 (s, 1H), 8.58 (s, 1H), 8.77 (s, 1H); 13C NMR and JMOD
(75 MHz, CDCl3)
d 153.4 (C), 151.4 (C), 147.7 (CH), 144.5 (CH), 142.5
(CH), 140.7 (C), 140.2 (C), 133.3 (C), 133.1 (C), 132.4 (CH), 130.9 (C),
129.5 (CH), 129.2 (CH), 128.69 (CH), 128.66 (CH), 127.6 (CH), 125.0
(CH), 124.6 (CH), 117.8 (C), 113.3 (CH), 108.6 (CH), 101.9 (CH), 94.3
(C), 86.2 (C). HRMS (ESI/ASAP) m/z calculated for C30H21N2O
[MþH]þ: 425.1654, found 425.1757.
4.17. General procedure C for oxidative coupling
4.13. 2-[4-(2,6-Diphenyl-pyran-4-ylidenemethyl)-phenyl-
ethynyl]-4,6-dimethyl-pyrimidine (12)
I2 (255 mg, 1 mmol) was added to a solution of methylenepyran
(compounds 5e9) (0.2 mmol) in CH2Cl2 (20 mL). After being stirred
at room temperature overnight, the resulting black greenish mix-
ture was quenched with saturated Na2S2O3 aqueous solution
(20 mL). The mixture was kept under stirring for another 1 h, and
then the orange organic layer was separated, washed with H2O,
dried over MgSO4, and concentrated in vacuo.
Orange solid; obtained according to the general procedure B and
purified by column chromatography (SiO2, Petroleum Ether/CH2Cl2,
1:1 then CH2Cl2/MeOH, 95:5); yield 47% (213 mg); mp: 185e186 ꢁC;
1H NMR (400 MHz, CDCl3)
d
2.51 (s, 6H), 5.89 (s, 1H), 6.42 (s, 1H),
6.96 (s, 1H), 6.99 (s, 1H), 7.44e7.35 (m, 8H), 7.63 (d, 2H, J¼8 Hz),
7.77e7.74 (m, 4H); 13C NMR and JMOD (75 MHz, CDCl3)
167.0 (C),
d
153.3 (C), 152.8 (C), 151.3 (C), 140.0 (C), 133.3 (C), 133.1 (C), 132.8
(CH), 130.7 (C), 129.4 (CH), 129.1 (CH), 128.7 (CH), 128.6 (CH), 127.4
(CH), 125.0 (CH), 124.6 (CH), 118.7 (CH), 117.9 (C), 113.5 (CH), 108.6
(CH), 102.0 (CH), 88.6 (C), 87.8 (C). HRMS (ESI/ASAP) m/z calculated
for C32H24N2O [M]þ: 452.1889, found 452.1883.
4.18. Bispyrane derivative (16)
Red solid; obtained according to the general procedure C and pu-
rified by column chromatography (SiO2, CH2Cl2); yield 45% (40 mg);
mp: 188 ꢁC (dec); 1H NMR (300 MHz, THF-d8)
d 6.86 (s, 2H), 7.22 (s,
2H), 7.69e7.48 (m, 20H), 7.80 (d, J¼8.4 Hz, 4H), 7.89 (d, J¼8.4 Hz, 4H),
7.90 (d, J¼6.9 Hz, 4H), 7.96 (d, J¼6.9 Hz, 4H); 13C NMR and JMOD
4.14. 4-[4-(2,6-Diphenyl-pyran-4-ylidenemethyl)-phenyl-
ethynyl]-6-methoxy-pyrimidine (13)
(75 MHz, THF-d8) d 154.2 (C),153.4 (C),143.9 (C),134.9 (C),133.6 (CH),
133.4 (CH), 133.1 (CH), 131.1 (CH), 130.7 (CH), 130.6 (CH), 130.1 (CH),
130.0 (CH),129.5 (C),126.0 (CH),125.5 (C),121.3 (C),119.3 (C),113.2 (C),
107.4 (CH), 105.5 (CH), 95.2 (C), 89.5 (C). HRMS (ESI/ASAP) m/z cal-
culated for C66H40N2O2 [M.]þ: 892.3084, found 892.3090.
Orange solid; obtained according to the general procedure B and
purified by column chromatography (SiO2, Petroleum Ether/CH2Cl2,
1:1); yield 65% (244 mg); mp: 155e156 ꢁC; 1H NMR (400 MHz,
CDCl3)
d
4.00 (s, 3H), 5.89 (s, 1H), 6.41 (d, 1H, J¼2 Hz), 6.88 (d, 1H,
J¼2 Hz), 6.99 (d,1H, J¼2 Hz), 7.38 (d, 2H, J¼8 Hz), 7.44e7.40 (m, 6H),
4.19. Bispyrane derivative (17)
7.56 (d, 2H, J¼8 Hz), 7.77e7.74 (m, 4H), 8.76 (d, 1H, J¼2 Hz); 13C
NMR and JMOD (75 MHz, CDCl3)
d 169.7 (C), 158.5 (CH), 153.4 (C),
Red solid; obtained according to the general procedure C and
purified by column chromatography (SiO2, hexane/CH2Cl2, 1:1);
yield 30% (28 mg); mp: 192 ꢁC (dec); 1H NMR (500 MHz, THF-d8)
151.4 (C), 150.7 (C), 140.3 (C), 133.3 (C), 133.1 (C), 132.5 (CH), 130.9
(C), 129.5 (CH), 129.2 (CH), 128.7 (CH), 128.6 (CH), 127.6 (CH), 125.0
(CH), 124.6 (CH), 117.6 (CH), 113.3 (CH), 110.3 (CH), 108.6 (CH), 101.9
(CH), 93.6 (C), 87.1 (C), 54.0 (CH3). HRMS (ESI/ASAP) m/z calculated
for C31H23N2O2 [MꢀH]þ: 455.1759, found 455.1751.
d
6.85 (d, J¼2.0 Hz, 1H), 7.23 (d, J¼2.0 Hz, 1H), 7.50e7.68 (m, 10H),
7.40e7.49 (m, 4H), 7.95 (d, J¼7.2 Hz, 2H), 8.40 (d, J¼8.9 Hz, 2H); 13
C
NMR (125 MHz, THF-d8)
d 154.2, 153.4, 148.7, 144.1, 134.9, 134.8,
133.6,133.2,131.5, 131.2, 130.7, 130.6,130.1,130.0,126.1,126.0,125.4,
125.0, 121.2, 107.4, 105.6, 96.2, 89.3. HRMS (ESI/ASAP) m/z calcu-
lated for C64H40N2O6 [M.]þ: 932.2881, found 932.2880.
4.15. 4,6-Bis-[4-(2,6-diphenyl-pyran-4-ylidenemethyl)-phe-
nylethynyl]-pyrimidine (14)
Red solid; obtained according to the general procedure B and
purified by column chromatography (SiO2, Petroleum Ether/CH2Cl2,
4:1 then CH2Cl2, then CH2Cl2/MeOH 93:7); yield 72% (554 mg); mp:
4.20. Bispyrane derivative (18)
Orange solid; obtained according to the general procedure C and
purified by column chromatography (SiO2, Petroleum Ether/CH2Cl2,
204 ꢁC (dec); 1H NMR (400 MHz, CDCl3)
d
5.92 (s, 2H), 6.44 (s, 2H),